124 related articles for article (PubMed ID: 38686788)
81. The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.
Ozluk Y; Pehlivan E; Gulluoglu MG; Poyanli A; Salmaslioglu A; Colak N; Kapran Y; Yilmazbayhan D
Int J Surg Pathol; 2011 Dec; 19(6):761-71. PubMed ID: 21791482
[TBL] [Abstract][Full Text] [Related]
82. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
83. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
84. Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology.
Aliyev A; Patel J; Brainard J; Gupta M; Nasr C; Hatipoglu B; Siperstein A; Berber E
Surgery; 2016 Jan; 159(1):113-7. PubMed ID: 26454673
[TBL] [Abstract][Full Text] [Related]
85. Incidence of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and change in risk of malignancy for "The Bethesda System for Reporting Thyroid Cytology".
Sung S; Margolskee E; Chen D; Tiscornia-Wasserman P
J Am Soc Cytopathol; 2019; 8(3):133-140. PubMed ID: 31097289
[TBL] [Abstract][Full Text] [Related]
86. Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy.
Yilmaz N; Cansu GB; Toru S; Sari R; Ocak GG; Arici C; Altunbas HA; Balci MK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S53-S58. PubMed ID: 33380652
[TBL] [Abstract][Full Text] [Related]
87. Validation of the Bethesda System for Reporting Thyroid Cytopathology in a Danish tertiary centre.
Madsen SH; Jespersen ML; Bonnema SJ; Rolighed L; Swan KZ
Dan Med J; 2024 May; 71(6):. PubMed ID: 38847411
[TBL] [Abstract][Full Text] [Related]
88. A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.
Ng DL; van Zante A; Griffin A; Hills NK; Ljung BM
Thyroid; 2021 Jul; 31(7):1086-1095. PubMed ID: 33371796
[No Abstract] [Full Text] [Related]
89. Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy: A Retrospective Analysis.
Wang M; Sun P; Zhao X; Sun Y
Cancer Control; 2020; 27(1):1073274820945976. PubMed ID: 33035078
[TBL] [Abstract][Full Text] [Related]
90. Examining the Bethesda criteria risk stratification of thyroid nodules.
Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
[TBL] [Abstract][Full Text] [Related]
91. Thyroid malignancy rates according to the Bethesda reporting system in Israel - A multicenter study.
Madgar O; Avior G; Shochat I; Joshua BZ; Baraf L; Avidor Y; Avi Khafif ; Assadi N; Alon EE
Eur J Surg Oncol; 2021 Jun; 47(6):1370-1375. PubMed ID: 33745793
[TBL] [Abstract][Full Text] [Related]
92. Efficiency of the Bethesda System for Thyroid Cytopathology.
Mora-Guzmán I; Muñoz de Nova JL; Marín-Campos C; Jiménez-Heffernan JA; Cuesta Pérez JJ; Lahera Vargas M; Torres Mínguez E; Martín-Pérez E
Cir Esp (Engl Ed); 2018; 96(6):363-368. PubMed ID: 29605452
[TBL] [Abstract][Full Text] [Related]
93. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population.
Vuong HG; Suzuki A; Na HY; Tuyen PV; Khuy DM; Nguyen HC; Jitpasutham T; Abelardo A; Amano T; Park SY; Jung CK; Hirokawa M; Katoh R; Kakudo K; Bychkov A
Am J Clin Pathol; 2021 Apr; 155(5):680-689. PubMed ID: 33269383
[TBL] [Abstract][Full Text] [Related]
94. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
Singh RS; Wang HH
Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
[TBL] [Abstract][Full Text] [Related]
95. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
96. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
[TBL] [Abstract][Full Text] [Related]
97. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
[TBL] [Abstract][Full Text] [Related]
98. Comparative study of fine needle aspiration cytology and histopathology in thyroid nodules at a tertiary care hospital: First report from Somalia.
Abdullahi IM; Yasin NA; Dirken ES; Mohamoud AM; Guler I; Adani AA
Asian J Surg; 2023 Oct; 46(10):4202-4207. PubMed ID: 36504151
[TBL] [Abstract][Full Text] [Related]
99. Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.
Liu X; Medici M; Kwong N; Angell TE; Marqusee E; Kim MI; Larsen PR; Cho NL; Nehs MA; Ruan DT; Gawande A; Moore F; Barletta J; Krane JF; Cibas ES; Yang T; Alexander EK
Thyroid; 2016 Feb; 26(2):256-61. PubMed ID: 26563459
[TBL] [Abstract][Full Text] [Related]
100. The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.
Kiernan CM; Broome JT; Solórzano CC
Ann Surg Oncol; 2014 Oct; 21(11):3522-7. PubMed ID: 24796967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
